Clinical Relevance of Drug–Drug Interactions with Darolutamide

Long-term Treatment Outcome With Niraparib in Patients With Recurrent Ovarian Cancer: Results From the ENGOT-OV16/NOVA Trial

Five Years of Follow-Up From the Phase 3 RESONATE-2 Study and Nursing Experience With Patients Receiving First-Line Ibrutinib for Chronic Lymphocytic Leukemia

Nursing Considerations for the Use of Isatuximab in the Treatment of Multiple Myeloma

Role of the Clinical Oncology Nurse in the Malignant Pleural Mesothelioma-Tumor Treating Fields Patient Journey

Malignant Pleural Mesothelioma and Tumor Treating Fields: Nurses’ Impact on Symptom Management

Encorafenib plus Cetuximab With or Without Binimetinib for BRAF V600E–Mutant Metastatic Colorectal Cancer: Management of Adverse Events from a Randomized, 3-Arm, Phase 3 Study vs. the Choice of Either Irinotecan or FOLFIRI plus Cetuximab (BEACON CRC)

Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial